Mexico vs Russian Federation: Tuberculosis treatment success rate by type
Mexico
69
in 2023
Russian Federation
68
in 2023
Mexico rank
155th
Russian Federation rank
157th
Tuberculosis treatment success rate by type over time
- Mexico
- Russian Federation
How they compare
Mexico currently reports 69 against 68 in Russian Federation, a difference of 1.
The two have swapped places 2 times across 28 shared years of data; in 1995 it was Mexico ahead.
Mexico ranks 155th and Russian Federation ranks 157th of 194 countries.
Mexico has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Mexico | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 70.4 | 64.4 | 6 | Mexico |
| 2000s | 79.67 | 67 | 12.67 | Mexico |
| 2010s | 78.8 | 68.6 | 10.2 | Mexico |
| 2020s | 70.25 | 64.25 | 6 | Mexico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate by type, Mexico or Russian Federation?
- Mexico, at 69 against 68 in Russian Federation as of 2023.
- What is the difference in tuberculosis treatment success rate by type between Mexico and Russian Federation?
- 1, with Mexico ahead.
- How many years of comparable data are there for Mexico and Russian Federation?
- 28 years are reported by both, from 1995 to 2023.
- How do Mexico and Russian Federation rank globally for tuberculosis treatment success rate by type?
- Mexico ranks 155th and Russian Federation ranks 157th of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The treatment success rate refers to the share of people diagnosed with tuberculosis (TB) who were either cured or completed their treatment according to the country’s treatment guidelines.